N-Acetyl-seryl-aspartyl-lysyl-proline inhibits DNA synthesis in human mesangial cells via up-regulation of cell cycle modulators
- 14 April 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 342 (3) , 758-765
- https://doi.org/10.1016/j.bbrc.2006.02.019
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 23 references indexed in Scilit:
- Triggering p53 after cytokinesis failureThe Journal of cell biology, 2004
- Distinct roles for p53, p27Kip1, and p21Cip1 during tumor developmentOncogene, 2003
- Cyclooxygenase-2 Overexpression Inhibits Platelet-derived Growth Factor-induced Mesangial Cell Proliferation through Induction of the Tumor Suppressor Gene p53 and the Cyclin-dependent Kinase Inhibitors p21waf-1/cip-1 and p27kip-1Journal of Biological Chemistry, 2002
- Akt Serine Threonine Kinase Regulates Platelet-derived Growth Factor-induced DNA Synthesis in Glomerular Mesangial CellsJournal of Biological Chemistry, 2001
- Mdm2 association with p53 targets its ubiquitinationOncogene, 1998
- Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.Journal of Clinical Investigation, 1996
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Tumor-suppressor p53 and the cell cycleCurrent Opinion in Genetics & Development, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Involvement of thymosin β4 and endoproteinase Asp‐N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic systemFEBS Letters, 1990